p161.html
P161 Unmet needs in the treatment of idiopathic pulmonary fibrosis (IPF) – insights from patient chart review in five european countries
Fri, 18 Aug 2023 19:24:00 GMT
Introduction and objectives Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the FDA and EMA for the treatment of IPF. We investigated treatment patterns of European patients with ...